LBNano is dedicated to the development of next-generation liquid biopsy technologies for prevention, early detection, and prognosis of human diseases. Our pioneered point-of-care (POC) device can be used in either a clinician’s office, hospital or at home.
Our technologies are centered on nanopore sensing, fluorescent assay, microfluidics, and machine learning. By taking advantage of a panel of biomarkers, LBNano developed a wide variety of home-testing kits for highly sensitive and accurate disease diagnosis.
In addition to medical diagnosis of various diseases such as cancer, cardiovascular diseases, infectious diseases, alzheimer's disease and sepsis, our device offers the potential use in the fields of food safety/biodefense, environmental monitoring, and pharmaceutical industry.
Copyright © 2023 Lbnanotech - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.